COMPETENCE IN NUCLEAR MEDICINE
Deutsch
English
Français
Italiano
Anker
Inhalt Top

EFDEGE®

Fludeoxyglucose [18F] solution injectabilis

Therapeutic indications

This pharmaceutical is a diagnostic reagent for the positron emission tomography (PET) and is administered prior to such an examination.  

EFDEGE is a radiopharmaceutical diagnostic reagent for tumour detection.

The radioactive agent of EFDEGE (for displaying the glucose metabolism) is recorded by the PET and displayed as an image.

EFDEGE is indicated for imaging PET procedures within the framework of oncological diagnostics for examining the function and diseases, aiming at displaying an increased glucose intake in specific organs and tissues. The following areas of application are sufficiently documented:

Diagnosis

  • Characterisation of solitary pulmonary nodules
  • Metastatic cervical adenopathy of unknown origin

Determination of the tumour stage

  • Primary lung carcinomas, including the detection of pulmonary distant metastases
  • Carcinomas of the head and neck region, including the support of the PET controlled biopsy
  • Recurrent colorectal carcinomas
  • Malignant lymphomas
  • Malignant melanomas: Breslow > 1.5 mm or lymph node metastases at the first diagnosis

Monitoring of the therapeutic response

  • Carcinomas of the head and neck region
  • Malignant lymphomas

Detection in cases of serious grounds for recurrences

  • Carcinomas of the neck and head region
  • Primary lung carcinomas
  • Colorectal carcinomas  
  • Malignant lymphomas
  • Malignant melanomas 

CLINICAL PARTICULARS

Approvals

Approval number Date of registration Country PDF
4-00020 25.05.2004 Austria SPC
6511 IE 1 F 12 24.07.2006 Belgium SPC
59726.00.00 22.06.2004 Germany SPC
564 456-4 15.12.2003 France SPC
68514/2-12-2004 31.12.2004 Greece SPC
RVG 30417 03.02.2005 Netherlands SPC
036751016/M 19.12.2005 Italy SPC
UP/I-530-09/09-01/15 18.12.2009 Croatia SPC
1523/04070003 30.07.2004 Luxembourg SPC
12105 15.02.2006 Poland SPC
5628383 28.10.2005 Portugal SPC
5363-I-1174/11 (11ml) 12.12.2005 Slovenia SPC
5363-I-1175/11 (25ml) 12.12.2005 Slovenia SPC
88/328/05-C 19.10.2005 Czech Republic SPC
OGYI-T-10441/01 15.09.2005 Hungary SPC
Inhalt Bottom